Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.57 Analyst target: $16.33 Upside: 535.41%
Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development, manufacture and marketing of pharmaceuticals for inflammatory and immune-related diseases. The company is headquartered in Markham, Canada.
See the full interactive analysis & chart →Informational only — not investment advice.